FTL and cancer: The results showed that FTL was upregulated in 21 of the 27 cancers analyzed (77.8%), downregulated in three cancers (11.1%; CHOL, LAML, LUSC), and not significantly changed in three cancers (11.1%; BLCA, KICH, KIRP) compared with normal tissues (Figure 1A).